The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetes

Abstract

AMI patients with hyperglycaemia on admission, independent of a history of diabetes, represent a high-risk population for 180-day mortality. The worst outcome occurs in non-diabetic hyperglycaemic patients. Further studies are warranted to clarify the questions of hyperglycaemia treatment in AMI patients.